Unilife Corporation - Alan Shortall - The Wall Street Transcript

Healthcare >> CEO Interviews >> March 19, 2012

Alan Shortall is the Founder, CEO and Executive Director of Unilife Corporation, a U.S.-based medical device and technology company that designs, develops, manufactures and supplies innovative, differentiated delivery systems for injectable drugs and vaccines. Since 2002, Mr. Shortall has led the growth of the company's products into one of the most diversified portfolios of drug delivery systems, positioning the company to be a global leader in the industry. Mr. Shortall spearheaded the transition of the Australia-founded company into a registered U.S. business listed on the Nasdaq Global Exchange under the symbol UNIS, and it continues to be traded on the Australian Stock Exchange under the symbol UNS. Mr. Shortall is committed to the growth of Unilife Corporation, creating strong shareholder value as well as enhancing and saving the lives of millions worldwide who are at risk from unsafe injection practices. In recognition of his substantial marketing and commercial experience and solid leadership of Unilife Corporation, Mr. Shortall, in 2008, was named to the list of 100 Notable People in the medical device industry by trade magazine Medical Device and Diagnostic Industry, or MD&DI. In January 2010, Mr. Shortall was profiled on the front cover of Drug Delivery Technology magazine. Profile

TWST: Would you start by giving us an overview of Unilife, its history and its activities?

Mr. Shortall: We design, develop and manufacture innovative drug-delivery systems. In particular, we have a

Join for free to read a longer excerpt or purchase this article

Unilife Corporation – Alan Shortall

Top Company Interviews

CEO INTERVIEWS

SECTOR ROUNDTABLES

MONEY MANAGER INTERVIEWS

ANALYST INTERVIEWS